The rapidly increasing use The book ends wvith a short statement of general conclusions in which the panel point out there is no evidence at present to suggest that steroid hormones are ultimate carcinogens but rather that they act by modification of pituitary hormone secretion in wlich prolactin is a factor. From available human data, the group rather guardedly concludes that oral contraceptives have not as yet been shown to affect the risk of breast cancer although they remain uncommitted with respect to evidence relating to cervical cancer.
There is no evidence that administration of steroidal oestrogens for treatment of menopausal syndrome is associated with cancer risk but diethylstilboestol administered during pregnancy w ould appear to expose female off-spring to risk of vaginal or cervical adenocarcinoma and probably increases the risk of endometrial carcinoma in women with gonadal dysgenesis.
The panel have performed a much needed and Herculean task in collating and critically assessing all the relevant information linking hormones and carcinogenesis. Any omissions would appear to be due to lack of sound, published information rather than inadequate coverage, and it is noted that revised monographs w-ill be published as new data become available.
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